| Latest Forum Topics / Q&M Dental Last:0.505 -- |
 Post Reply
|
|
Q&M dental
|
|||||
|
Joelton
Supreme |
14-Aug-2026 09:35
|
||||
|
x 0
x 0 Alert Admin |
Q& M Dental&rsquo s 1HFY2026 earnings up 27% y-o-y to $4.9 mil declares interim dividend of 0.4 cents per share Q& M Dental (SGX:QC7) has reported earnings of $4.9 million for 1HFY2026 ended June 30, an increase of 27% y-o-y. Profit after tax from its core dental business stood at $15 million for the same period, up 10% y-o-y. Revenue for the same period was up by 13% y-o-y to $99.5 million, much supported by the topline growth from its core dental business, which recorded a 13% y-o-y increase in revenue to $98.6 million. The higher revenue from its core dental business was driven by stronger contributions from its dental clinics and equipment and supplies distribution businesses in Singapore and Malaysia. The growth was partially offset by lower profit guarantee income. Finance costs increased 57% y-o-y to $3.7 million, driven by the interest payable on the $130 million 3.95% notes issued under its $500 million multicurrency debt issuance programme in last July. Employee benefits expense rose 16% y-o-y to $59.9 million, in line with higher clinic revenue in Singapore and other incentives directed at retaining clinical and management talent. As at June 30, Q& M Dental&rsquo s cash and cash equivalent stood at $119.2 million, up 2% from $117.1 million as at Dec 31, 2025. The board of Q& M Dental has declared a first interim dividend of 0.4 cent per share, unchanged from the corresponding period. Looking ahead, Q& M Dental&rsquo s immediate priority is to work towards the successful completion of the Australian and Thai acquisitions, subject to the fulfilment of the respective condition&rsquo s precedent. &ldquo Our priority now is to complete these transactions and to integrate them well, while continuing to grow in Singapore, Malaysia and the PRC with the same discipline that brought us here,&rdquo says Ng Chin Siau, Q& M Dental&rsquo s CEO. Shares of Q& M Dental closed unchanged at 55 cents on Aug 13. |
||||
| Useful To Me Not Useful To Me | |||||
|
PiRPiR
Master |
24-Jul-2026 12:59
|
||||
|
x 0
x 0 Alert Admin |
Q&M Dental is acquiring dental groups in Australia and Thailand in a combined US$113.2 million push to build a pan-Asia dental company, the group announced on Sunday. It also said that it would defer further action on plans for a secondary listing on Bursa Malaysia, first announced in April 2025. Shares of Q&M last traded at S$0.555 on Thursday, before it called for a trading halt. The halt was lifted on Monday. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Joelton
Supreme |
18-Jul-2026 13:30
|
||||
|
x 0
x 0 Alert Admin |
PhillipCapital&rsquo s Chew reiterates upbeat call on Q& M with acquisitions in Australia and Thailand After years of operating the largest network of private dental outlets in Singapore, Q& M Dental Group (SGX:QC7) , having raised a $130 million war chest through a bond issue, has taken concrete steps towards its ambitious plan to expand overseas, confirming its moves into Australia and Thailand. At its July 10 event, Q& M&rsquo s executives reiterated their ambition to create the largest dental company in the Asia-Pacific region, which will allow the dental healthcare group to capitalise on the region&rsquo s rapid growth in the middle and upper-class population, as well as increasing healthcare awareness. For the planned expansion in Australia, Q& M Dental will pay A$119.64 million ($107 million) for all of Experteeth Group, which operates 40 clinics and is staffed by around 120 dentists across New South Wales, Victoria, Queensland, Tasmania and the Australian Capital Territory. Q& M Dental&rsquo s founder and CEO, Dr Ng Chin Siau, says Australia is one of the region&rsquo s most established and tightly regulated healthcare markets and that the scale and clinical depth could give the dental group a strong operating base for growth. &ldquo We are pleased that the Experteeth Group&rsquo s founding dentist shareholders will continue to play an active role as strategic partners as we work together to expand the platform over the coming years,&rdquo says Ng. At the same time, Q& M Dental will pay THB994.5 million ($39 million) for a 51% stake in Deezy Q& M Dental Group (Thailand) Co, which operates a network of 33 dental clinics nationwide. &ldquo Thailand has long been a market of interest for us, and Deezy stands out as the right partner for our next step forward. The clinic&rsquo s network, its professional team and the reputation Deezy has built over the years give us confidence in its growth potential, and we are looking forward to growing this business together in the years ahead,&rdquo Ng shares. Following the latest corporate updates, Paul Chew of PhillipCapital has maintained his &ldquo buy&rdquo call and an unchanged target price of 71 cents. Chew notes that the combined purchase consideration of some $146 million will be satisfied with $92 million in cash, plus the issuance of 86.7 million new shares. The new shares represent 9.1% of the existing shares issued at Q& M Dental. &ldquo The newly issued shares are placed under a 15-year moratorium and are being issued at a price consideration of 70 cents per share,&rdquo Chew adds. Based on Chew&rsquo s calculations, the combined acquisitions in Australia and Thailand are valued at a P/E ratio of 11.4 (Australia: 10 times Thailand: 16 times). &ldquo The total purchase consideration of $146 million is largely backed by a profit guarantee of six to eight years, which adds up to $126 million,&rdquo Chew says. &ldquo The implied earnings growth backed by the profit guarantee is around 13%, with Thailand&rsquo s earnings growth to be the highest at 22% in terms of CAGR,&rdquo he adds. Overall, Chew believes that these acquisitions will be positive for Q& M Dental. &ldquo The acquisitions will increase our FY2026 earnings per share (EPS) forecast by 1.04 cents or 54% to 2.96 cents, which excludes amortisation of intangibles. As such, Q& M Dental&rsquo s valuation is being lowered to just 18 times the P/E ratio,&rdquo Chew says. Apart from that, Chew believes the acquisitions will help accelerate Q& M Dental&rsquo s growth trajectory through the faster-growing geographies of Australia and Thailand and that they are backed by profit guarantees. &ldquo Lastly, the 15-year share moratorium cum service agreement and profit guarantees ensure that there is alignment of interest to build and grow this Asia Pacific franchise. There are also synergies through group procurement, training, and best practices,&rdquo Chew adds. Chew has pegged Q& M Dental&rsquo s valuation at a 25 times P/E ratio for FY2026, in line with the Singapore healthcare sector, resulting in an unchanged target price of 71 cents. The analyst adds that its 57.12%-owned Aoxin Q& M Dental is valued at market valuation, while the acquisitions have not been incorporated |
||||
| Useful To Me Not Useful To Me | |||||
|
PiRPiR
Master |
13-Jul-2026 13:10
|
||||
|
x 0
x 0 Alert Admin |
11:16 PM EDT, 07/12/2026 (MT Newswires) -- Q&M Dental (Singapore) (SGX:QC7) agreed to acquire Experteeth Group in Australia for AU$119.6 million, according to a Sunday filing with the Singapore Exchange.
Experteeth owns 40 clinics and 120 dentists across Australia. The consideration includes AU$64.6 million in cash, with AU$45.9 million to be paid on completion and AU$18.8 million deferred, subject to profit targets. Meanwhile, the remaining AU$55 million will be paid in the form of shares at SG$0.70 per share. Additionally, the deal is underpinned by an eight-year profit guarantee of around AU$112.6 million. |
||||
| Useful To Me Not Useful To Me | |||||
|
tkchua
Member |
13-Jul-2026 12:26
|
||||
|
x 0
x 0 Alert Admin |
Very positive news is bast time to accumulate this stock | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Joelton
Supreme |
13-Jul-2026 09:24
|
||||
|
x 0
x 0 Alert Admin |
Q& M Dental Group inks Australia, Thailand deals worth US$113.2 million in pan-Asia push defers Bursa Malaysia listing [SINGAPORE] Q& M Dental Group is acquiring dental groups in Australia and Thailand in a combined US$113.2 million push to build a pan-Asia dental company. In separate bourse filings on Sunday (Jul 12), the group confirmed the two acquisitions and separately said it would defer further steps on its previously announced plan for a secondary listing on Bursa Malaysia, which it first announced in April 2025. It added that the acquisitions support its long-term strategy of expanding beyond Singapore and strengthening its presence across the Asia-Pacific region. Q& M will acquire 100 per cent of Experteeth Dental Group, which operates 40 clinics across New South Wales, Victoria, Queensland, Tasmania and the Australian Capital Territory, under six brands including Elevate Dental Group, Lumiere Dental Group and Ace Dental Group, with a clinical team of about 120 dentists. Separately, it will also take a 51 per cent effective interest in Deezy Q& M Dental Group through a holding structure in which a wholly acquired vehicle, QDD Venture, will hold 49.9 per cent of Deezy directly, plus a further 2.2 per cent through a joint venture company. Deezy Q& M Dental Group is Thailand&rsquo s leading dental care brand with 33 clinics. The two deals are valued at a combined US$112.7 million. The Experteeth Group acquisition is worth A$119.64 million (US$83.3million), comprising A$64.6 million in cash and A$55 million in Q& M consideration shares. The shares are issued at S$0.70 apiece, a 25.7 per cent premium to the stock&rsquo s volume-weighted average price of S$0.557 on Jul 9, the last full trading day before the sale and purchase agreement was signed. They represent about 7.4 per cent of Q& M&rsquo s existing share capital and are subject to a 15-year moratorium. The Deezy Q& M Dental Group transaction is worth 994.5 million baht (US$29.9 million), comprising 700 million baht in cash and 294.5 million baht in Q& M consideration shares. These shares are also issued at S$0.70 apiece &ndash the same 25.7 per cent premium &ndash and represent about 1.73 per cent of Q& M&rsquo s existing share capital, and are also under a 15-year moratorium. Separately, Q& M will inject about A$30.4 million of equity into Experteeth Group on completion, mainly to repay existing financing facilities and fund expansion. The Australia deal&rsquo s profit guarantee, worth about A$112.6 million over eight years, requires the Experteeth Group&rsquo s audited net profit after tax to grow from A$10.3 million in the first year post-acquisition to about A$16.6 million by the sixth to eighth year, backed by an A$8 million escrow account &ndash reducing to A$5.5 million if the first-year target is met. Founders Jeffrey Gao and Hong Chang, along with six other key dentists, are guarantors under the Australia deal and will enter into 15-year service agreements. The founders will additionally serve as co-chief executive officers of the Experteeth Group under 15-year management agreements, and one is expected to join Q& M&rsquo s board as a director, with the other as his alternate. Pro forma disclosures show the Australia acquisition would lift the group&rsquo s earnings per share from S$0.0098 to S$0.0188, but would turn its net tangible asset (NTA) per share negative, from S$0.0589 to a negative S$0.024. The Thailand deal&rsquo s pro forma effect is milder: EPS would rise from S$0.0098 to S$0.0114, while NTA per share would fall from S$0.0589 to S$0.0386. The group already has an existing presence in Singapore, Malaysia and China, with its China dental assets housed under listed entity Aoxin Q& M. Thailand and Australia have been flagged as new major anchors for growth, alongside proposed 100 per cent acquisitions in central and southern China through Aoxin Q& M and a &ldquo strategic expansion&rdquo in Singapore. Why Australia, why Thailand The Australia deal carries an eight-year profit guarantee commitment, alongside a 15-year service agreement, a 15-year share moratorium and escrow protection to align vendors with the enlarged group over the long term. Meanwhile, the Thai transaction includes a six-year profit guarantee commitment, a 15-year service agreement, a 15-year share moratorium and escrow protection, worth 48.74 million baht, with either party facing a break fee of 0.88 per cent of the consideration if the deal&rsquo s conditions are not met within six months. Chief operating officer Raymond Ang said Q& M has eyed the Australian market since its initial public offering in 2009. &ldquo The rules for dentists in Australia are very similar to Singapore. It&rsquo s a place where we understand the rules, the laws and the financial standards,&rdquo he said. There is also potential in the sheer scale of the Australian market where there are about 20,000 dentists and 8,000 clinics, with even the largest existing dental group there running just over 100 clinics. Regional and rural areas &ndash mining and farming communities, for instance &ndash offer stronger economics too, with thinner competition and good spending power. These are areas which Experteeth already have a presence in and plan to expand further. Thailand fits the same Asia-Pacific growth thesis, with the deal&rsquo s 15-year service agreement and share moratorium designed to signal long-term alignment between the two groups. Deezy Q& M Dental Group will continue to be run by its local team under a similar group-practice model and philosophy to Q& M&rsquo s own, with Q& M providing capital and strategic know-how rather than taking over day-to-day operations. Q& M Group chief executive officer Ng Chin Siau said Q& M intends to keep growing across the Asia-Pacific region outside China, naming Japan, the Philippines and Indonesia as untapped markets under consideration for future expansion. Bursa Malaysia listing on hold Separately, Q& M&rsquo s previously announced plan for a secondary listing on Bursa Malaysia has been deferred. In a bourse filing, the company said the board will &ldquo defer further steps&rdquo and continue to consider the listing&rsquo s suitability with its advisers, &ldquo having regard to prevailing circumstances and the interests of the company and its shareholders&rdquo . The filing itself does not elaborate on the reasons for the deferral. Ng said Singapore&rsquo s new Equity Market Transformation Programme, a S$6.5 billion initiative aimed at making the Singapore stock market more vibrant and attractive for fundraising, is the reason why Q& M now intends to stay focused on Singapore for future fundraising rather than pursue the Malaysian dual listing. |
||||
| Useful To Me Not Useful To Me | |||||
|
tkchua
Member |
09-Jul-2026 19:48
|
||||
|
x 0
x 0 Alert Admin |
Q& M has Request trading halt tmr good or bad news |
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
17-Jun-2026 18:10
|
||||
|
x 0
x 0 Alert Admin |
Speaking to dentists, I was surprised to hear the general sentiment that the economics are not particularly attractive. This was in the context of whether dentistry was a good career path relative to say being a GP, but perhaps there is a lesson to be drawn in terms of business as well. | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Joelton
Supreme |
13-Jun-2026 14:21
|
||||
|
x 0
x 0 Alert Admin |
Q& M&rsquo s acquisition binge sets it up for structural growth shift Following the pandemic boost, Q& M Dental Group&rsquo s earnings have normalised, which made some investors overlook this stock in the last couple of years. But as investors start to forget about the stock, CEO Dr Ng Chin Siau has been laying the groundwork for ambitious growth plans. Instead of being contented with just organic growth here in Singapore, the company, armed with $130 million raised from a medium-term note (MTN), is in the midst of a multi-front acquisition binge in markets including Australia and Thailand. The company is also aiming to grow in China separately via its listed subsidiary, Aoxin Q& M Dental Group. As a result, the company&rsquo s growth story is attracting more positive coverage from analysts. The most recent to join the fray is Troy Cheng of OCBC Group Research, who initiated coverage on this counter with a &ldquo buy&rdquo call and a fair value of 76 cents. &ldquo Q& M&rsquo s strategic direction in 2026 marks a decisive shift from being a Singapore‑ focused clinic operator to building a diversified Asia Pacific dental platform,&rdquo says Cheng. Dental visits by elderly on the rise He observes that the frequency of dental visits by people here in Singapore rises sharply with age, with the 65&ndash 74 age cohort having the highest annual visitation rate at 73%. &ldquo This reflects structurally greater treatment needs among seniors, who require more frequent and higher‑ value interventions such as implants, periodontal therapy, dentures and restorative work. According to Cheng, middle-aged adults aged 35 to 64 are showing rising utilisation, too. &ldquo This cohort represents the largest share of Singapore&rsquo s resident population and benefits from expanding insurance coverage, higher health awareness and growing willingness to invest in oral wellness,&rdquo he says. Cheng is of the view that operators with scale and accessibility, such as Q& M, are best positioned to capture incremental demand, with its brand recognition providing a form of natural leverage among elderly patients, the fastest-growing segment. Acquisition spree Next, Q& M is embarking on an active growth bid through a series of acquisitions outside its home base in Singapore, which currently accounts for the largest share of revenue. Once it completes the targeted acquisitions in Australia and Thailand, alongside ongoing expansion in Malaysia and China, the company&rsquo s revenue base is set to diversify meaningfully across five Asia Pacific markets. &ldquo This marks a structural shift from single‑ market dependence to a multi‑ market regional platform, reducing concentration risks while expanding the addressable market,&rdquo says Cheng. Q& M pays for its acquisitions by enticing dentists to take shares as well, with lengthy moratoriums of up to 15 years. From Cheng&rsquo s perspective, this is a way to reduce the risk of talent flight, since attrition is a &ldquo persistent&rdquo risk in the healthcare business. &ldquo We view this as a best-practice incentive design for a talent-dependent business model,&rdquo he says. Last but not least, Q& M possesses an &ldquo underappreciated technology asset&rdquo in its tech subsidiary, EM2AI, which is an &ldquo embedded recurring revenue stream&rdquo not yet fully priced in by the market. Cheng says that EM2AI&rsquo s AI-powered solutions serve more than 1,100 clinics across five countries, generating Software-as-a-Service-like subscription income that diversifies Q& M beyond pure clinic revenue. &ldquo As digital dentistry adoption accelerates across Southeast Asia, EM2AI&rsquo s network effect &mdash and the data advantage it generates &mdash will compound in value,&rdquo says Cheng. Key risks On the other hand, the key risk is elevated leverage with the series of acquisitions. Cheng notes that with the $130 million debt, Q& M&rsquo s net debt-to-equity ratio reached 19% for FY2025, a &ldquo significant step-up&rdquo from historical norms. Upon completion of the acquisitions in Australia, Thailand, and Singapore, leverage rises materially. Cheng estimates FY2026 net debt at around $268.5 million, implying a net debt-to-equity ratio of around 1.9 times, well ahead of earnings contributions, which will only build from FY2027 onwards as the acquired clinics scale. While the MTN carries a fixed 3.95% coupon, a prolonged higher-for-longer rate environment beyond the MTN&rsquo s tenor could increase refinancing costs. &ldquo If the three acquisitions close simultaneously before earnings accretion materialises, the group may face pressure to raise equity to manage leverage, which would dilute existing shareholders,&rdquo warns Cheng. Cheng also points out that as Q& M deepened its China exposure by consolidating Aoxin Q& M as a subsidiary. According to Cheng, the government is increasingly scrutinising foreign-affiliated healthcare providers. &ldquo Any regulatory crackdown, pricing controls or licensing restrictions could impair Aoxin&rsquo s earnings contribution, just as it becomes more material to group profitability,&rdquo he says. With Q& M poised to have a significant presence in numerous markets, it is exposing itself to multi-currency translation risk as it reports in the Singapore dollar, which has gained against other currencies, he says. In the most recent FY2025, the company reported lower earnings. Still, Cheng points out that its core earnings remain stable and that the drop was due to accounting effects from the consolidation of Aoxin Q& M and EM2AI, rather than a deterioration in underlying operations. As such, Cheng&rsquo s view is reinforced that headline historical figures understate the platform&rsquo s true earnings power. He expects revenue to grow at a 13.8% CAGR between FY2026 and FY2030, reaching $376.8 million. In contrast, earnings are expected to grow faster, from $9.3 million to $35.4 million over the same period, driven by operating leverage. |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
24-Apr-2026 11:46
|
||||
|
x 0
x 0 Alert Admin |
Q& M&rsquo s Ng in married deal with Asdew Acquisitions, Han Seng Juan and Bryan Lim involving 27 mil shares at 60 cents each Dr Ng Chin Siau, founder and CEO of Q& M Dental Group (SGX:QC7) , is yet again involved in another private, off-market transactions with external parties. In an April 23 SGX filing, Quan Min Holdings, an entity used by Ng and related parties to control Q& M Dental Group, disposed 27 million shares in the company on April 22 to Asdew Acquisitions, Han Seng Juan, and Bryan Lim via married deal. With a total consideration of $16.2 million, excluding brokerage and stamp duties, this translates to a price of 60 cents per share. The previous round of married deal, which involves Ng as well, occurred back in April 10, where Q& M Dental Group disposed 30 million shares of Aoxin (SGX:1D4) via married deal to Lion Global Investors. Shares of Q& M Dental closed 1.5 cents lower, or 2.48% down at 59 cents on April 23. |
||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
22-Apr-2026 15:44
|
||||
|
x 0
x 0 Alert Admin |
28m marroed deal at 60cents so far | ||||
| Useful To Me Not Useful To Me | |||||
|
tkchua
Member |
22-Apr-2026 15:40
|
||||
|
x 0
x 0 Alert Admin |
Never before see such a huge volume more excitement in the pipeline
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
piscesmonkey
Supreme |
22-Apr-2026 11:53
|
||||
|
x 0
x 0 Alert Admin |
Now 18m married deal
|
||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
22-Apr-2026 11:37
|
||||
|
x 0
x 0 Alert Admin |
10m married deal at 60cents. Aoxin going chiong up
|
||||
| Useful To Me Not Useful To Me | |||||
|
PQTPQK
Supreme |
22-Apr-2026 11:33
|
||||
|
x 0
x 0 Alert Admin |
Heavy vol today .. | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
18-Apr-2026 16:36
|
||||
|
x 0
x 0 Alert Admin |
Q& M&rsquo s acquisition spree inspires higher target prices, but execution is key Q& M Dental Group (SGX:QC7) , making no bones about its growth ambitions, has managed to attract some market interest. With its war chest recently replenished by a bond issue, the company has launched concurrent acquisitions of other dental groups in Thailand, Singapore, Australia and China via its separately listed subsidiary, Aoxin Q& M Dental Group. Q& M, led by founder and CEO Ng Chin Siau, has managed to secure institutional backing for his ventures, too. Notably, Lion Global Investors (LGI) had spent $9 million to buy 20 million shares at 45 cents each. More recently, LGI also took a stake in Aoxin (SGX:1D4) , paying $5.4 million to acquire 30 million shares from Q& M at 18 cents each. Following this deal, Q& M&rsquo s stake in Aoxin has been trimmed to 52.93%. Year to date, Q& M and Aoxin shares have gained 9.1% and 19.4% respectively, extending a gain of 114.3% and 377.8% since the start of 2025. However, while turning a bit more optimistic about the company, analysts covering this counter prefer to see whether the company can pull off this multi-pronged execution before they turn fully bullish on it. Paul Chew of PhillipCapital estimates that the total value of the acquisitions, to be paid using a combination of cash and shares, will be around $272 million. With more than 70 dental clinics to be added to the just over 100 that Q& M already operates. Depending on how the acquisitions are structured, these new clinics, estimates Chew, can bring in a profit guarantee of some $200 million over a five- to eight-year period, which varies from deal to deal, but alone will help generate earnings growth of 14% per year for the next three years. Upon completion of the acquisitions, Q& M could double its earnings. Chew&rsquo s post-acquisition earnings estimate for the current FY2026 is 3.5 cents per share, up 80%. His fair value, excluding amortisation of intangibles, is 95 cents per share. However, for now, Chew is applying a 50% discount on the earnings accretion from the pending completion of the acquisitions, leading nonetheless to a higher target price of 71 cents, up from 54.5 cents previously Prospects will shape up, but not immediately. &ldquo We view the long tenure of the share moratorium, service agreement and profit guarantee as equivalent to a permanent partnership to grow and scale up a new franchise and platform,&rdquo says Chew. More recently, Eric Ong of Maybank Securities has kept his call for this counter at &ldquo hold&rdquo as he believes that at current levels, Q& M&rsquo s share price represents a relatively balanced risk-reward ratio. Nonetheless, citing the ongoing acquisitions, Ong has raised his target from 43 cents to 64 cents. He likes this stock for possessing better capital flexibility, which is put to good use with the &ldquo strong desire&rdquo to expand significantly beyond the traditional markets of Singapore and Malaysia. As Q& M is still undertaking due diligence on these targets, Ong has not factored in the potential earnings contribution into his forecasts, given the timing and completion uncertainty. Based on Ong&rsquo s best-case scenario prediction, which is the completion of all three acquisitions by the end of this year, Q& M could potentially double its FY2027 earnings per share to three cents. &ldquo The total purchase amount for the acquisitions is about $270 million, with 60% of the consideration funded through cash and bank borrowings, and the remaining 40% consideration through equity (via the issuance of new shares), respectively,&rdquo Ong predicts. In the best-case scenario, he estimates a fair value of around 75 cents for Q& M, using a target multiple of 25 times the FY2027 fully diluted P/E ratio. In the worst-case scenario, which is the failure to complete all three M& As, Ong estimates Q& M could achieve a net profit of $14.3 million in FY2027, purely from organic growth driven by market share gains amid the continued expansion of its clinic network in Singapore and Malaysia. &ldquo Based on this scenario, our fair value would be 53 cents, pegged at the FY2027 P/E ratio of 35 times. We use a higher P/E ratio multiple due to lower execution and integration risks associated with organic expansion, while it is also able to channel its robust cash holdings of $117 million as at Dec 31, 2025, towards additional share buybacks and higher dividend payouts to shareholders instead of pursuing acquisitions,&rdquo Ong says. |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
15-Apr-2026 12:18
|
||||
|
x 0
x 0 Alert Admin |
Maybank maintains &lsquo hold&rsquo for Q& M despite ambitious growth strategy execution of M& A key to re-rating Eric Ong of Maybank Securities has maintained a &ldquo hold&rdquo call and target price of 64 cents for Q& M Dental Group (SGX:QC7) (Q& M), given the relatively balanced risk-reward ratio for the ongoing potential M& As. In his April 14 report, Ong points out that Q& M recently embarked on an ambitious growth strategy through M& As across Australia, Thailand, Singapore, and China. &ldquo Notably, its expansion drive is supported by enhanced capital flexibility and a strong desire to quickly diversify its footprint beyond the traditional markets of Singapore and Malaysia,&rdquo Ong states. Last July, Q& M raised $130 million in notes under its $500 million multi-currency debt issuance programme, with net proceeds primarily intended to accelerate its M& A strategy. &ldquo To align interests with all parties, it is seeking a partnership-driven acquisition model with long-term service agreements and the issuance of Q& M shares subject to a moratorium as part of the consideration,&rdquo Ong adds. The analyst mentions that given the dental group is still undertaking due diligence on these targets, he has not factored in the potential earnings contribution into his forecasts given the timing and completion uncertainty. Based on Ong&rsquo s best-case scenario prediction, which is the completion of all three M& As, he forecast that Q& M could potentially double its FY2027&rsquo s earning per share to three cents assuming all three M& A are done by the end of this year. &ldquo The total purchase amount for the acquisitions is about $270 million, with 60% of the consideration funded through cash and bank borrowings, and the remaining 40% consideration through equity (via the issuance of new shares), respectively,&rdquo Ong predicts. With the best-case scenario, he estimates a fair value of around 75 cents for Q& M by using a target multiple of 25 times FY2027 fully diluted P/E ratio. On a worst-case scenario basis, which is failure to complete all three M& As, Ong estimates Q& M could achieve a net profit of $14.3 million in FY2027, purely from organic growth, contributed by market share gains amid the continued expansion of its clinic network in Singapore and Malaysia. &ldquo Based on this scenario, our fair value would be 53 cents, pegged at FY2027 P/E ratio of 35 times. We use a higher P/E ratio multiple due to lower execution and integration risks associated with organic expansion, while it is also able to channel its robust cash holdings of $117 million as at 31 Dec, 2025, towards additional share buybacks and higher dividend payouts to shareholders instead of pursuing acquisitions,&rdquo Ong says. |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
14-Apr-2026 08:26
|
||||
|
x 0
x 0 Alert Admin |
Q& M and Lion Global Investors in married deal for 30 mil Aoxin shares changing hands at 18 cents each In an SGX filing dated April 13, Q& M Dental Group (Q& M) announced that on April 10, it has disposed 30 million shares of Aoxin Q& M Dental Group (Aoxin) via married deal to Lion Global Investors. With a total consideration of $5.4 million, excluding brokerage and stamp duties, this translates to a price of 18 cents per share. Following the April 10 married deal, Q& M&rsquo s stake in Aoxin has reduced from 55.87% to 52.93%. Back on March 27, Aoxin announced its plan to acquire a China-based dental group for RMB150 million, of which Aoxin will pay cash of RMB75 million and issue new shares at 30 cents each to fund the balance. So far, there has been no further announcement on this proposed acquisition. As at 9.51am, Aoxin shares are trading flat at 20.5 cents. Its share price has seen a gain of 310% for the past one year. |
||||
| Useful To Me Not Useful To Me | |||||
|
JurongW
Elite |
09-Apr-2026 20:24
Yells: "Earnings give weight, Chart give wings" |
||||
|
x 0
x 0 Alert Admin |
QM holdings bought 3,719,700 shares at $0.6012 on 9 Apr https://links.sgx.com/1.0.0/corporate-announcements/NH89IDFXNGMR6A4A/882821__eFORM3V2-09042026-QMH.pdf |
||||
| Useful To Me Not Useful To Me | |||||
|
JurongW
Elite |
08-Apr-2026 23:04
Yells: "Earnings give weight, Chart give wings" |
||||
|
x 0
x 0 Alert Admin |
QM holdings bought 4,095,100 shares at $0.5856 on 8 Apr https://links.sgx.com/1.0.0/corporate-announcements/S3SSAMHWLXRKIR6U/882612__eFORM3V2-08042026-QMH.pdf |
||||
| Useful To Me Not Useful To Me | |||||